Previous Article | Next Article ![]()
Infect Immun, February 1998, p. 692-695, Vol. 66, No. 2
Center for Vaccine Development, Department of
Medicine, University of Maryland School of Medicine, Baltimore,
Maryland 21201,1 and
Department of
Microbiology, Dartmouth Medical School, Hanover, New Hampshire
037552
Received 29 May 1997/Returned for modification 23 September
1997/Accepted 26 November 1997
In this study, adult volunteers were fed tcpA and
mshA deletion mutants of V. cholerae O139
strain CVD 112 to determine the role of toxin-coregulated pili (TCP)
and mannose-sensitive hemagglutinin (MSHA) in intestinal colonization.
Eight of 10 volunteers who received CVD 112 or CVD 112
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Investigation of the Roles of Toxin-Coregulated Pili and
Mannose-Sensitive Hemagglutinin Pili in the Pathogenesis of
Vibrio cholerae O139 Infection
mshA shed the vaccine strains in their stools; the
geometric mean peak excretion for both groups was 1.4 × 105 CFU/g of stool. In contrast, only one of nine
recipients of CVD 112
tcpA shed vibrios in his stool
(P < 0.01); during the first 24 h after
inoculation, 3 × 102 CFU/g was recovered from this
volunteer. All recipients of CVD 112 and 8 (80%) of the recipients of
CVD 112
mshA developed at least a fourfold rise in
vibriocidal titer after immunization. In contrast, only one (11%) of
the nine recipients of CVD 112
tcpA developed a fourfold
rise in vibriocidal titer (P < 0.01). We conclude
that TCP are an important colonization factor of V. cholerae O139 and probably of El Tor V. cholerae O1.
In contrast, MSHA does not appear to promote intestinal colonization in
humans.
*
Corresponding author. Mailing address: Center for
Vaccine Development, 685 West Baltimore St., Room 480, Baltimore, MD
21201. Phone: (410) 706-5328. Fax: (410) 706-4171. E-mail:
ctacket{at}umppa1.ab.umd.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|